Tairen Capital LTD Zai Lab LTD Transaction History

Tairen Capital LTD

  • $2.85 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 18, 2021
SELL
$126.27 - $191.71 $2.73 Million - $4.14 Million
-21,600 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$81.94 - $135.34 $1.12 Million - $1.86 Million
13,726 Added 174.32%
21,600 $2.92 Million
Q3 2020

Nov 16, 2020
BUY
$73.3 - $89.48 $577,164 - $704,565
7,874 New
7,874 $655,000

Others Institutions Holding ZLAB

# of Institutions
121
Shares Held
46.7M
Call Options Held
223K
Put Options Held
588K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.63B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Tairen Capital LTD Portfolio

Follow Tairen Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tairen Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tairen Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email